NewsRoom Articles

FridayNov 14, 2025 9:45 am

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Targets Glioblastoma with Innovative Therapies, Addressing One of Oncology’s Greatest Unmet Needs

Glioblastoma multiforme (“GBM”) is an aggressive brain cancer with limited treatment options, and CEO John Climaco emphasized the company’s commitment to overcoming the blood-brain barrier, a key obstacle in brain cancer therapy. Lead candidate TPI 287, an abeotaxane, has shown early evidence of appearing to cross the blood-brain barrier and producing clinical responses. Phase 2 planning is underway following encouraging data from a Phase 1 combination study with bevacizumab (Avastin). The company’s repurposed global clinical network and regulatory progress position it for potential late-stage development in 2026. TPI 287 holds multiple Orphan Drug Designations, covering gliomas, neuroblastoma, and other CNS-related…

WednesdayNov 12, 2025 10:00 am

UK Government Announces $18.4M in Awards to Support Quantum Computing Projects

British officials have allocated $18.4 million in awards to support over a dozen quantum computing projects. The Quantum Sensing Mission Primer awards' goal is quite ambitious: deploy quantum computers that surpass current supercomputers by 2036. Science minister Patrick Vallance called the technology revolutionary, noting that it could transform medical diagnostics and slash computation times from decades to seconds. Cumulatively, the UK has pledged $880 million to advance quantum technology development in the country. Innovate UK will fund practical applications in medicine and infrastructure across 14 projects. One team is building a handheld eye scanner to replace the room-sized machines hospitals…

MondayNov 10, 2025 10:00 am

New Implants Defy Necessity of Brain Surgery Against Cancer

Microscopic wireless electronics that self-navigate to diseased brain tissue could eliminate the need for surgery when treating tumors and neurological conditions. Massachusetts Institute of Technology researchers demonstrated the technology in mice, showing how tiny devices injected into the bloodstream can autonomously locate target regions and deliver electrical stimulation without human guidance. These implants are fused with immune cells before injection, allowing them to slip past the body's defenses and cross the blood-brain barrier intact. Each device measures roughly one-billionth of a rice grain's length, built from layered organic semiconducting polymers positioned between metallic components to create an electronic structure. Scientists…

WednesdayNov 05, 2025 10:00 am

Cancer Immunotherapy Could Be Transformed by Boosting Natural Killer Cells

Researchers at MIT and Harvard Medical School have developed a method to enhance natural killer cells that could transform cancer immunotherapy. The team engineered chimeric antigen receptor natural killer cells with modifications that prevent immune system rejection and improve their ability to destroy tumors. Early experiments in mice and laboratory human tissue show the enhanced cells are effective at fighting cancer and well tolerated, offering a promising foundation for next-generation treatments. Natural killer cells function as the body's first defense against virus-infected or cancerous tissue. They react immediately to suspect cells without requiring activation or priming. Chimeric antigen receptors engineered…

MondayNov 03, 2025 10:00 am

China Moves to End Subsidies to its EV Industry

Beijing has removed electric vehicles from its list of strategic emerging industries for the first time in over a decade, signaling a fundamental shift in how the world's largest automotive market will support its dominant EV sector. The exclusion of NEVs from China's 2026-2030 five-year development plan indicates policymakers believe the industry has matured enough to compete without tens of billions’ worth of government subsidies and customer incentives. Market forces rather than policy directives will now determine which manufacturers survive China's increasingly competitive EV market. Data from Jato Dynamics research shows that 93 of the 169 automakers currently operating in…

WednesdayOct 29, 2025 9:00 am

AMD Shares Jump as IBM Says its Existing Chips Can Correct Quantum Computing Errors

AMD shares surged by nearly 8% on Friday after IBM announced that standard AMD chips can run a critical quantum computing error correction algorithm. Investors' response to the breakthrough in qubit technology advancement caused IBM stock to climb approximately 8% as well, heading toward its best single-day performance since January. A recent report revealed that IBM can successfully operate error correction algorithms in real time on AMD's field programmable gate array chips, marking significant progress toward building commercially viable quantum computers. The development addresses one of quantum computing's most persistent challenges: managing the errors that plague qubit-based systems that can…

MondayOct 27, 2025 10:00 am

Scientists Uncover Possible Driver of ‘Chemo Brain’

A recent study has found that the cognitive difficulties which cancer patients experience during and after treatment could stem from chemotherapy-induced damage to the brain's waste drainage network. Newly discovered evidence sheds light on a widespread yet poorly understood phenomenon that affects up to 75% of individuals undergoing cancer therapy, chemo brain. The symptoms associated with this condition, including memory lapses and problems with concentration and finding words, typically persist long after treatment is complete. Published in the journal Communications Biology, the study examined how common cancer drugs impact meningeal lymphatics, specialized vessels within the brain membranes responsible for waste…

WednesdayOct 22, 2025 10:00 am

Study Suggests mRNA Covid Vaccine Could Boost Cancer Immunotherapy

New research published at the European Society for Medical Oncology conference on Sunday has revealed that the mRNA coronavirus vaccine could have an unintended benefit: boosting immunotherapy effectiveness. Although the research is still in its initial phases, experts say Covid vaccines may be able to improve immune function during immunotherapy and make the treatment more potent. Immunotherapy is a relatively new cancer treatment that uses a patient's immune system to fight tumor cells, avoiding the side effects typically associated with chemotherapy and radiation. The connection between coronavirus vaccines and improved immunotherapy efficacy will be explored further in a Phase 3…

MondayOct 20, 2025 10:00 am

Chinese EV Exports Doubled YoY in September, Data Shows

Chinese automakers shipped 222,000 electric and plug-in hybrid vehicles internationally through September, marking a 100% surge compared to the prior year. The China Association of Automobile Manufacturers reported the figures alongside domestic passenger car sales that climbed 11.2% over the same period. These numbers reveal resilient demand despite intense competitive pressures that are fragmenting the world's largest automotive market. The export acceleration shows how manufacturers are increasingly depending on foreign sales to compensate for deteriorating margins at home. Domestic price wars have created substantial pressure for Chinese automakers and pushed them to aggressively pursue growth opportunities overseas. Recent investment allocation…

MondayOct 13, 2025 10:00 am

New AI Tool Boosts Precision Medicine in Treating CNS Cancers

Harvard Medical School researchers have developed an AI system that distinguishes glioblastoma from other brain tumors during surgery. The tool called PICTURE achieved 99.8% accuracy in differentiating glioblastoma from primary central nervous system lymphoma. This rare malignancy is frequently misdiagnosed as glioblastoma, yet the AI system outperformed nine human neuropathologists who misclassified lymphoma as glioblastoma in 38% of test cases. With over 100 distinct subtypes, central nervous system tumors involve exceptional diagnostic complexity. Glioblastoma represents the most common variety, with patients typically receiving surgical tumor removal but facing a median survival of just eight months. Primary CNS lymphoma shares overlapping…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000